277 related articles for article (PubMed ID: 22447230)
1. Haptoglobin genotype and its role in diabetic cardiovascular disease.
Costacou T; Levy AP
J Cardiovasc Transl Res; 2012 Aug; 5(4):423-35. PubMed ID: 22447230
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease.
Blum S; Milman U; Shapira C; Levy AP
Pharmacogenomics; 2008 Aug; 9(8):989-91. PubMed ID: 18681772
[No Abstract] [Full Text] [Related]
3. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.
Asleh R; Levy AP
Vasc Health Risk Manag; 2005; 1(1):19-28. PubMed ID: 17319095
[TBL] [Abstract][Full Text] [Related]
4. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
Dalan R; Liuh Ling G
Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
[TBL] [Abstract][Full Text] [Related]
5. Haptoglobin phenotype and coronary artery collaterals in diabetic patients.
Hochberg I; Roguin A; Nikolsky E; Chanderashekhar PV; Cohen S; Levy AP
Atherosclerosis; 2002 Apr; 161(2):441-6. PubMed ID: 11888529
[TBL] [Abstract][Full Text] [Related]
6. The genetics of vascular complications in diabetes mellitus.
Farbstein D; Levy AP
Cardiol Clin; 2010 Aug; 28(3):477-96. PubMed ID: 20621252
[TBL] [Abstract][Full Text] [Related]
7. Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene.
Levy AP
Acta Diabetol; 2003 Dec; 40 Suppl 2():S330-3. PubMed ID: 14704863
[TBL] [Abstract][Full Text] [Related]
8. Haptoglobin: a major susceptibility gene for diabetic cardiovascular disease.
Levy AP
Isr Med Assoc J; 2004 May; 6(5):308-10. PubMed ID: 15151377
[No Abstract] [Full Text] [Related]
9. Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.
Costacou T; Secrest AM; Ferrell RE; Orchard TJ
Diab Vasc Dis Res; 2014 Sep; 11(5):335-42. PubMed ID: 24994788
[TBL] [Abstract][Full Text] [Related]
10. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Levy AP; Gerstein HC; Miller-Lotan R; Ratner R; McQueen M; Lonn E; Pogue J
Diabetes Care; 2004 Nov; 27(11):2767. PubMed ID: 15505023
[No Abstract] [Full Text] [Related]
11. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Blum S; Vardi M; Levy NS; Miller-Lotan R; Levy AP
Atherosclerosis; 2010 Jul; 211(1):25-7. PubMed ID: 20223458
[No Abstract] [Full Text] [Related]
12. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.
Costacou T; Ferrell RE; Orchard TJ
Diabetes; 2008 Jun; 57(6):1702-6. PubMed ID: 18332093
[TBL] [Abstract][Full Text] [Related]
13. The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes.
Somer S; Levy AP
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396615
[TBL] [Abstract][Full Text] [Related]
14. Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosis.
Purushothaman M; Krishnan P; Purushothaman KR; Baber U; Tarricone A; Perez JS; Wiley J; Kini A; Sharma SK; Fuster V; Moreno PR
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2769-75. PubMed ID: 22982461
[TBL] [Abstract][Full Text] [Related]
15. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.
Levy AP; Hochberg I; Jablonski K; Resnick HE; Lee ET; Best L; Howard BV;
J Am Coll Cardiol; 2002 Dec; 40(11):1984-90. PubMed ID: 12475459
[TBL] [Abstract][Full Text] [Related]
16. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.
Vardi M; Blum S; Levy AP
Eur J Intern Med; 2012 Oct; 23(7):628-32. PubMed ID: 22939808
[TBL] [Abstract][Full Text] [Related]
17. Hp1-1 as a Genetic Marker Regulating Inflammation and the Possibility of Developing Diabetic Complications in Patients with Type 2 Diabetes-Cohort Studies.
Stempkowska A; Walicka M; Franek E; Naruszewicz M; Panczyk M; Sanchak Y; Filipek A
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114431
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis--haptoglobin genotype and diabetic nephropathy.
Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP
Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716
[TBL] [Abstract][Full Text] [Related]
19. Haptoglobin genotype and the iron hypothesis of atherosclerosis.
Viener HL; Levy AP
Atherosclerosis; 2011 May; 216(1):17-8. PubMed ID: 21353224
[No Abstract] [Full Text] [Related]
20. Haptoglobin genotype and its role in determining heme-iron mediated vascular disease.
Goldenstein H; Levy NS; Levy AP
Pharmacol Res; 2012 Jul; 66(1):1-6. PubMed ID: 22465143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
